Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Epiphany Biosciences Inc
Profile last edited on: 12/30/19      CAGE: 4TK98      UEI: YDMZF9MLC6S6

Business Identifier: Therapeutics for pathogenic viruses
Year Founded
2006
First Award
2008
Latest Award
2019
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

One California Street Suite 2800
San Francisco, CA 94111
   (415) 765-7193
   info@epiphanybio.com
   www.epiphanybio.com
Location: Single
Congr. District: 12
County: San Francisco

Public Profile

Epiphany Biosciences, Inc. develops and markets therapeutic products and diagnostic technologies that treat and prevent the spread of pathogenic viruses. The company develops therapeutics to prevent spread of varicella zoster virus (VZV), Epstein-Barr virus (EBV), and hepatitis C virus (HCV).

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
1
Conversion Rate
100.00%
Phase I Dollars
$112,978
Phase II Dollars
$4,797,505
Total Awarded
$4,910,483

Synopsis: Awardee Business Condition

Employee Range
100-149
Revenue Range
10M-15M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2019 2 NIH $4,910,483
Project Title: Improved Diagnosis of Kaposi's Sarcoma Herpes Virus Infection

Key People / Management

  Fred G Volinsky -- Co-Founder, Chairman and CEO

  Steven Blank -- Co-Founder

  Steven Dong -- Director of Drug Discovery and Development

  Christian Hofmann -- Business Development

  Michael Houghton -- Chief Scientific Officer

  Brian Murphy -- Chief Medical Officer

Company News

There are no news available.